| Autor: |
Dayre McNally, Karin Amrein, Katharine O’Hearn, Dean Fergusson, Pavel Geier, Matt Henderson, Ali Khamessan, Margaret L. Lawson, Lauralyn McIntyre, Stephanie Redpath, Hope A. Weiler, Kusum Menon, on behalf of the Canadian Critical Care Trials Group |
| Jazyk: |
angličtina |
| Rok vydání: |
2017 |
| Předmět: |
|
| Zdroj: |
Pilot and Feasibility Studies, Vol 3, Iss 1, Pp 1-13 (2017) |
| Druh dokumentu: |
article |
| ISSN: |
2055-5784 |
| DOI: |
10.1186/s40814-017-0214-z |
| Popis: |
Abstract Background Clinical research has recently demonstrated that vitamin D deficiency (VDD) is highly prevalent in the pediatric intensive care unit (PICU) and associated with worse clinical course. Multiple adult ICU trials have suggested that optimization of vitamin D status through high-dose supplementation may reduce mortality and improve other clinically relevant outcomes; however, there have been no trials of rapid normalization in the PICU setting. The objective of this study is to evaluate the safety and efficacy of an enteral weight-based cholecalciferol loading dose regimen in critically ill children with VDD. Methods/design The VITdAL-PICU pilot study is designed as a multicenter placebo-controlled phase II dose evaluation pilot randomized controlled trial. We aim to randomize 67 VDD critically ill children using a 2:1 randomization schema to receive loading dose enteral cholecalciferol (10,000 IU/kg, maximum of 400,000 IU) or a placebo solution. Participants, caregivers and outcome assessors will be blinded to allocation. Eligibility criteria include ICU patient, aged 37 weeks to 18 years, expected ICU length of stay more than 48 h, anticipated access to bloodwork at 7 days, and VDD (blood total 25 hydroxyvitamin D |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
